New T2 injectable
Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for the treatment of adults with Type 2
Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for the treatment of adults with Type 2
GlucoRx was formed in 2010, although its Sales Director Chris Chapman had been with its sister company, Disposable Medical Equipment Ltd for five years before
We can’t tell you his real name, as that would be breaking protocol, and we’d hate to blow his cover. This is the Grumpy Pumper,
Sweet Freedom’s Choc Pot is super smooth and delicious tasting with 75% less fat and half the calories of the leading chocolate spread, and importantly,
GPs and practice nurses across the country may be able to improve care for thousands of patients with Type 2 diabetes, thanks to a partnership
A United Nations initiative — International Day of Women and Girls in Science — took place earlier this year to promote and encourage the participation
Three years ago Alix Avery, a product designer and yo-yo dieter, had a ‘light-bulb’ moment. Having wanted to change her eating habits permanently, she’d had
The BiAP is the bio-inspired artificial pancreas. We have an update on progress of this British-based endeavour. Moving overseas, we have another research report on
Injections have become one of the most common healthcare procedures across the world with more than 16 billion treatments estimated to be given via injections
Research published at the end of 2016 by Sanofi showed that negative emotions are jeopardising the ability of people living with Type 2 diabetes (T2D)